You are on page 1of 1

BROKENSHIRE COLLEGE

Madapo, Davao City


DRUG STUDY
Name of Client: Baumol, Prince Age: 4 Sex: Male Date of Birth: Marital Status: Child Religion: Islam
Chief Complaint/ Reason for Admission: Skin lesions and blisters with itchiness Date and Time of Admission: November 27, 2019 Accompanied by/ Informant: Mother
Medical Diagnosis/ Impression: Chronic bullous disease as childhood ogtt periphigorel Operation Perform (if any):
GENERIC BRAND GENERAL MECHANISM OF ROUTE OF INDICATION CONTRAINDICATION ADVERSE NURSING
NAME NAME CLASSIFICATION ACTION DOSAGE REACTION RESPONSIBILITY
Clindamycin Antibiotic/Anti-infectives Inhibits bacterial protein synthesis by IVTT q8 Infections caused by sensitive Patients hypersensitive to drug or lincomycin. CNS: headache - Assess patients infection before
binding to 5OS sub-unit of ribosome. staphylococci, streptococci, CV: thrombophlebeitis and regularly throughout therapy.
pneumococci, bacteroides, Use cautiously in patients with renal or EENT: pharyngitis - Before giving first dose, obtain
Hinders or kills susceptible bacteria. fusibacterium, clostridium, hepatic disease, asthma, history of GI disease, GI: abdominal pain, anorexia, specimen for culture and
perfringens, and other or significant allergies. bloody or tarry stools, constipation, sensitivity test, begin therapy
sensitive aerobic and diarrhea, dysphagia, esophagitis, pending results.
anaerobic organisms. flatulence, nausea, - Monitor renal, hepatic, and
pseudomembranous colitis, hematopoetic functions during
Unpleasant or bitter taste, vomiting. prolonged therapy.
GU: UTI - Be alert for adverse reactions and
Hematologic: eosinophilia, drug interactions.
thrombocytopenia, transient - If adverse GI reactions occurs,
Leukopenia monitor patients hydration
SKIN: maculopapular rash, - Instruct patient to report diarrhea
urticarial and to avoid self-threatening
Other: anaphylaxis, erythema, pain pseudomembranous colitis
(IV use), induration, pain, sterile - Tell patient receiving drug through
abcess. IV to report discomfort at infusion
site.

Submitted by: Alexa-Rae P. Zagado SNBC Clinical Instructor: Sir Cresencio Cajigal, RN, MN
Year and Section: BSN-III Date Submitted: November 28, 2019

You might also like